|
|
Previous Article | Table of Contents | Next Article 
Genotypic characterization of centrocytic lymphoma: frequent rearrangement
of the chromosome 11 bcl-1 locus
ME Williams, CD Westermann and SH Swerdlow
Department of Internal Medicine, University of Virginia Health Sciences
Center, Charlottesville 22908.
Centrocytic lymphomas are defined in the Kiel classification as B-cell
lymphomas composed exclusively of cells resembling cleaved follicular
center cells (FCC). These lymphomas have been shown to be histologically,
immunophenotypically, and clinically distinct from other cleaved FCC
lymphomas. DNA from 18 centrocytic lymphomas (14 patients) was analyzed
using Southern blotting and probes for immunoglobulin heavy (JH) and kappa
light chain (JK) joining gene, T- cell receptor beta chain constant gene
(CB), bcl-1, bcl-2, and c-myc gene rearrangements. All of the lymphomas had
JH and JK rearrangements, confirming their B-cell origin. None of the
specimens had detectable CB, bcl-2, or c-myc rearrangements. However, 4 of
14 patients (28.6%) had rearrangement of the chromosome 11 bcl-1 locus.
Therefore, centrocytic lymphomas are genotypically distinguishable from the
majority of other small cleaved FCC lymphomas by their lack of demonstrable
bcl-2 rearrangements. This supports the distinct nature of centrocytic
lymphomas and suggests the lack of importance for the putative oncogene
bcl-2 in these cases. Furthermore, the frequent rearrangement of bcl-1
suggests a possible role for this locus in the pathogenesis of at least
some centrocytic lymphomas.
Volume 76,
Issue 7,
pp. 1387-1391,
10/01/1990
Copyright © 1990 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Herens, F. Lambert, L. Quintanilla-Martinez, B. Bisig, C. Deusings, and L. de Leval
Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression
Blood,
February 1, 2008;
111(3):
1745 - 1746.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wiestner, M. Tehrani, M. Chiorazzi, G. Wright, F. Gibellini, K. Nakayama, H. Liu, A. Rosenwald, H. K. Muller-Hermelink, G. Ott, et al.
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
Blood,
June 1, 2007;
109(11):
4599 - 4606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Jennings and K. A. Foon
Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy
Blood,
October 15, 1997;
90(8):
2863 - 2892.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Ott, J. Bartkova, J. Bartek, A. Durr, L. Fischer, G. Ott, H. K. Muller-Hermelink, and H. Kreipe
Cyclin D1 Expression in Mantle Cell Lymphoma Is Accompanied by Downregulation of Cyclin D3 and Is Not Related to the Proliferative Activity
Blood,
October 15, 1997;
90(8):
3154 - 3159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ott, J. Kalla, M. M. Ott, B. Schryen, T. Katzenberger, J. G. Muller, and H. K. Muller-Hermelink
Blastoid Variants of Mantle Cell Lymphoma: Frequent bcl-1 Rearrangements at the Major Translocation Cluster Region and Tetraploid Chromosome Clones
Blood,
February 15, 1997;
89(4):
1421 - 1429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pinyol, L. Hernandez, M. Cazorla, M. Balbin, P. Jares, P. L. Fernandez, E. Montserrat, A. Cardesa, C. Lopez-Otin, and E. Campo
Deletions and Loss of Expression of P16INK4a and P21Waf1 Genes Are Associated With Aggressive Variants of Mantle Cell Lymphomas
Blood,
January 1, 1997;
89(1):
272 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. L. Bergsagel, M. Chesi, E. Nardini, L. A. Brents, S. L. Kirby, and W. M. Kuehl
Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma
PNAS,
November 26, 1996;
93(24):
13931 - 13936.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Amrein and D. J. Weissman
Case 43-1994- A 52-Year-Old Woman with Weakness, Diarrhea, and Diffuse Lymphadenopathy
N. Engl. J. Med.,
December 8, 1994;
331(23):
1576 - 1583.
[Full Text]
|
 |
|
|
|